|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02710032 |
|
Date of registration:
|
08/03/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru
TransPrEP |
|
Scientific title:
|
TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru |
|
Date of first enrolment:
|
July 1, 2017 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02710032 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Peru
| | | | | | | |
|
Contacts
|
|
Name:
|
Jesse L Clark, MD, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UCLA Geffen School of Medicine |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. 18 years of age or older;
2. Identify as male-to-female transgender (e.g., "trans," "transgender," "travesti");
3. Report behavioral risk for HIV infection (UAI with at least one HIV-infected or
unknown serostatus partner in the preceding 6 months);
4. HIV-uninfected by rapid test.
Exclusion Criteria:
1. Unable to provide informed consent, including people with severe mental illness
requiring immediate treatment or with mental illness limiting their ability to
participate (e.g., dementia);
2. HIV infection (Rapid HIV assay positive);
3. Active Hepatitis B infection (Hepatitis B Surface Antigen positive);
4. Renal insufficiency (Creatinine Clearance <50).
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV Infection
|
|
Intervention(s)
|
|
Behavioral: Social Media Platform
|
|
Behavioral: Social Network-Based Adherence Intervention
|
|
Primary Outcome(s)
|
|
Serum Drug Level
[Time Frame: 6 Months]
|
|
Secondary Outcome(s)
|
|
Hair Sample Drug Level
[Time Frame: 6 Months]
|
|
Self-reported Adherence
[Time Frame: 6 Months]
|
|
Secondary ID(s)
|
|
R34MH104072
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|